Institutional Biosafety Committee

Adam Clore, Ph.D. - Non-University Representative

Dr. Clore received his Ph.D. at Portland State University studying the evolution and genetics of the Fuselloviruses. After a post-doctoral fellowship researching mechanisms of DNA repair after exposure to genotoxins at Oregon Health and Science University he moved to his current position at Integrated DNA Technologies working as a technical specialist and in the development of products used in synthetic biology.  Dr. Clore can be reached by email. 

Lucy DesJardin, Ph.D. - Program Manager, State Hygienic Laboratory at The University of Iowa; Adjunct Faculty, College of Public Health

Dr. DesJardin received her Ph.D. in Molecular Genetics from the University of Florida, Department of Immunology and Medical Microbiology. She has worked with a variety of infectious agents, including postdoctoral studies on Mycobacterium tuberculosis cell wall biosynthesis and gene expression in response to chemotherapy. She has served as an operational manager for BioSafety Level III facilities. In 2002, she joined State Hygienic Laboratory as a Program Manager in Molecular Research and Development and has an adjunct faculty appointment with the Department of Epidemiology, University of Iowa College of Public Health. Current interests are in the development of molecular methods for the detection of microbial pathogens and genetic assays applicable to the Iowa Neonatal Metabolic Screening Program.  
Dr. DesJardin can be reached by email or phone, 319-335-4500.

Leonard R. Duncan, Ph.D. - Non-University Representative

Dr. Duncan received his Ph.D. at Harvard studying the process of sporulation in the gram-positive bacterium B. subtilis. Following a post-doctoral fellowship at Washington University in St. Louis, studying the development of Volvox, he worked for several years as a microbiologist at an antibiotic drug-discovery company in Dallas. In 2006, Dr. Duncan joined Vertex Pharmaceuticals where he was promoted to the rank of Research Fellow I and was project lead or biology lead on numerous antimicrobial discovery projects.  Since 2015, Dr. Duncan has worked at JMI Laboratories which specializes in monitoring global antimicrobial drug resistance and in conducting antimicrobial drug development studies for biotech and pharmaceutical companies. 
Dr. Duncan can be reached by email or phone, 319-665-3370 x240. 

Hillel Haim, M.D., Ph.D. - Assistant Professor, Microbiology

Dr. Haim received his M.D and Ph.D degrees from Hebrew University (Jerusalem, Israel). As a postdoctoral fellow at Harvard Medical School (Boston, MA) he studied the structure and function of the envelope glycoproteins of human immunodeficiency virus type 1 (HIV-1). Dr. Haim’s lab combines molecular and computational tools to study the mechanisms that viruses apply to persist in the host. Special attention is given to developing computational strategies to predict changes in structure of virus proteins, for tailoring therapeutics to patients and vaccines to populations.  
Dr. Haim can be reached by email or phone, 319-335-9989.  

Bradley D. Jones, Ph.D. - Associate Professor, Microbiology

Dr. Jones’s background is in bacterial genetics and pathogenesis. The focus of his research is to identify and characterize the virulence factors of pathogenic Francisella bacteria as well as Salmonella pathogens. His research involves bacterial genetic approaches to create mutants that are defective in various pathogenic mechanisms and then to identify the sites of mutation and characterize how the mutation affects bacterial virulence using in vitro and in vivo techniques. 
Dr. Jones can be reached by emial or phone, 319-353-5457.

Louis V. Kirchhoff, M.D., M.P.H., Chair - Professor, Internal Medicine (Infectious Diseases) & Epidemiology

Dr. Kirchhoff studies the molecular biology of Trypanosoma cruzi, the protozoan parasite that causes Chagas disease, and uses recombinant and non-recombinant approaches to develop serodiagnostic assays for this illness. 
Dr. Kirchhoff can be reached by email or phone, 319-335-6786.

Maria Martino-Cardona, D.V.M. - Clinical Veterinarian, Office of Animal Resources

Dr. Martino-Cardona received her D.V.M. from Cornell University in 2007. In 2010 she completed a residency in Laboratory Animal Medicine at Johns Hopkins University and became board certified in Laboratory Animal Medicine in 2010.  Dr. Martino-Cardona has been employed by the University of Iowa since 2010. 
Dr. Martino-Cardona can be reached by email or phone, 319-335-7985.

Nyree Mortensen, Ph.D., RBP, ARO - Associate Biosafety Officer, Environmental Health & Safety

Dr. Mortensen received her Ph.D. from Yale University where she conducted translational research with a main focus on the development of novel gene therapies for flaviviral infections. Prior to that, she received her M.S. from New Mexico State University where she researched the molecular determinants of transmission mode for viruses within the genus Flavivirus. Dr. Mortensen joined the Environmental Health & Safety Office in 2014. 
Dr. Mortensen can be reached by email or phone,  319-353-5679.

James T. Sheets, D.V. M. - Director, Office of Animal Resources

Dr. Sheets received his D.V. M. degree from Iowa State University in 1991 and following a 22 year career in the U.S. Army, joined the University of Iowa's veterinary staff in 2013. As Associate Director for the University's Office of Animal Resources (OAR), Dr. Sheets provides direct support to the OAR Director by assisting with oversight of the animal facility operations, veterinary care and animal husbandry programs, and the University's accreditation through the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC-I). Dr. Sheets also serves as a Council member for the AALAC-I Council on Accreditation. 
Dr. Sheets can be reached by email or phone, 319-335-7985.

Haley W. Sinn, Ph.D., CBSP, RO - Biological Safety Officer, Director - Environmental Health & Safety

Dr. Sinn received her Ph.D. and completed post-doctoral training at the University of Iowa; her research focused on characterizing novel Xin genes in mouse development and utilizing the fibronectin attachment protein of Bacillus Calmette-Guerin as a delivery vehicle for therapeutic drugs in the treatment of superficial bladder cancer, respectively. Dr. Sinn joined the Environmental Health & Safety Office in 2005. 
Dr. Sinn can be reached by email or phone, 319-335-9553.

Jack Stapleton, MD - Professor, Division of Infectious Diseases; Director, Levitt Center for Viral Pathogenesis

Dr. Stapleton received his M.D. from the University of Kansas, and completed Internal Medicine residency, Infectious Diseases and Microbiology fellowship training at the University of North Carolina. Dr. Stapleton conducts clinical-translational research on Human Immunodeficiency Virus (HIV), Hepatitis C Virus (HCV), and vaccines, and he conducts laboratory research related to virus-immune interactions using a variety of viral systems including HIV, HCV, vaccinia, and others. 
Dr. Stapleton can be reached by email or phone, 319-356-3168.

IBC Meetings

Meetings are held every other Thursday. For more information regarding meetings, please call or email the Biological Safety Officer - Haley Sinn, 319-335-9553.